Abstract | PURPOSE: MATERIALS AND METHODS: Early and delayed I-123 iomazenil SPECT images acquired 20 and 180 minutes after injection were compared with Tc-99m HMPAO SPECT studies acquired 15 to 20 minutes after injection in five patients with Alzheimer's disease. RESULTS: Visual analysis of I-123 iomazenil images showed more severe (n = 4) and extensive (n = 3) defects than did Tc-99m HMPAO. Semiquantitative analysis was performed by normalizing the uptake of Tc-99m HMPAO and I-123 iomazenil in individual brain regions in the cerebellum and expressing these values as a ratio of the occipital regions. The analysis of brain regional ratios in Tc-99m HMPAO studies showed a low but significant correlation with ratios of delayed (r = 0.325, P < 0.05) images in the I-123 iomazenil studies. Furthermore, when compared with Tc-99m HMPAO, early (P < 0.01) and delayed mean ratios (P < 0.05) were significantly less in the frontal regions; early mean ratios were significantly less in the temporal regions (P < 0.05), and delayed (P < 0.05) mean ratios were significantly less in the parietal regions. CONCLUSIONS:
|
Authors | A Varrone, A Soricelli, A Postiglione, M Salvatore |
Journal | Clinical nuclear medicine
(Clin Nucl Med)
Vol. 24
Issue 9
Pg. 660-5
(Sep 1999)
ISSN: 0363-9762 [Print] United States |
PMID | 10478740
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Iodine Radioisotopes
- Technetium Tc 99m Exametazime
- Flumazenil
- iomazenil
|
Topics |
- Alzheimer Disease
(diagnostic imaging, metabolism)
- Brain
(metabolism)
- Female
- Flumazenil
(analogs & derivatives, pharmacokinetics)
- Humans
- Iodine Radioisotopes
(pharmacokinetics)
- Male
- Middle Aged
- Technetium Tc 99m Exametazime
(pharmacokinetics)
- Tomography, Emission-Computed, Single-Photon
|